Vokes EE - Search Results

1

A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer.

Vokes EE, Schilsky RL, Choi KE, Magid DM, Guarnieri CM, Whaling SM, Ratain MJ, Weichselbaum RR, Panje WR. Vokes EE, et al. Cancer. 1989 Jan 1;63(1):30-6. doi: 10.1002/1097-0142(19890101)63:1<30::aid-cncr2820630105>3.0.co;2-m. Cancer. 1989. PMID: 2910422 Clinical Trial.

2

Intravenous 6-thioguanine or cisplatin, fluorouracil and leucovorin for advanced non-small cell lung cancer: a randomized phase II study of the cancer and leukemia group B.

Vokes EE, Lyss AP, Herndon JE 2nd, Cooper B, Perry MC, Vinciguerra V, Mason-Coughlin K, Green MR. Vokes EE, et al. Ann Oncol. 1992 Nov;3(9):727-32. doi: 10.1093/oxfordjournals.annonc.a058328. Ann Oncol. 1992. PMID: 1333267 Free article. Clinical Trial.

3

Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.

Vokes EE, Weichselbaum RR, Mick R, McEvilly JM, Haraf DJ, Panje WR. Vokes EE, et al. J Natl Cancer Inst. 1992 Jun 3;84(11):877-82. doi: 10.1093/jnci/84.11.877. J Natl Cancer Inst. 1992. PMID: 1375657 Clinical Trial.

4

Suramin: is adaptive control necessary?

Kobayashi K, Vokes EE, Stefansson K, Janisch L, Vogelzang NJ, Berezin F, Ratain MJ. Kobayashi K, et al. Among authors: vokes ee. J Clin Oncol. 1992 Dec;10(12):1984-5; author reply 1985-6. doi: 10.1200/JCO.1992.10.12.1984. J Clin Oncol. 1992. PMID: 1453214 No abstract available.

5

Continuous-infusion fluorodeoxyuridine with leucovorin and high-dose interferon: a phase II study in metastatic renal-cell cancer.

Stadler WM, Vogelzang NJ, Vokes EE, Charette J, Whitman G. Stadler WM, et al. Among authors: vokes ee. Cancer Chemother Pharmacol. 1992;31(3):213-6. doi: 10.1007/BF00685550. Cancer Chemother Pharmacol. 1992. PMID: 1464158 Clinical Trial.

6

The interaction of 5-fluorouracil, hydroxyurea, and radiation in two human head and neck cancer cell lines.

Vokes EE, Beckett M, Karrison T, Weichselbaum RR. Vokes EE, et al. Oncology. 1992;49(6):454-60. doi: 10.1159/000227092. Oncology. 1992. PMID: 1465284

7

Chemotherapy in head and neck cancer.

Hamasaki VK, Vokes EE. Hamasaki VK, et al. Among authors: vokes ee. Curr Opin Oncol. 1992 Jun;4(3):504-11. doi: 10.1097/00001622-199206000-00013. Curr Opin Oncol. 1992. PMID: 1498159 Review.

8

Molecular targets to overcome radioresistance.

Weichselbaum RR, Beckett MA, Hallahan DE, Kufe DW, Vokes EE. Weichselbaum RR, et al. Among authors: vokes ee. Semin Oncol. 1992 Aug;19(4 Suppl 11):14-20. Semin Oncol. 1992. PMID: 1509276 Review.

9

Perspectives on combination chemotherapy with concomitant radiotherapy for poor-prognosis head and neck cancer.

Vokes EE, Haraf DJ, Weichselbaum RR, McEvilly JM, Sutton HG, Panje WR. Vokes EE, et al. Semin Oncol. 1992 Aug;19(4 Suppl 11):47-56. Semin Oncol. 1992. PMID: 1509281

10

Concomitant chemoradiotherapy as investigational therapy for locoregionally advanced head and neck cancer.

Vokes EE. Vokes EE. Front Radiat Ther Oncol. 1992;26:55-63. doi: 10.1159/000421055. Front Radiat Ther Oncol. 1992. PMID: 1511923 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

566 results

Search Page

Filters